SG11201708680PA - Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr) - Google Patents

Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr)

Info

Publication number
SG11201708680PA
SG11201708680PA SG11201708680PA SG11201708680PA SG11201708680PA SG 11201708680P A SG11201708680P A SG 11201708680PA SG 11201708680P A SG11201708680P A SG 11201708680PA SG 11201708680P A SG11201708680P A SG 11201708680PA SG 11201708680P A SG11201708680P A SG 11201708680PA
Authority
SG
Singapore
Prior art keywords
tcr
activated
specific
cells expressing
cell receptor
Prior art date
Application number
SG11201708680PA
Other languages
English (en)
Inventor
Antonio Bertoletti
Sarene Koh
Original Assignee
Lion Tcr Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Tcr Pte Ltd filed Critical Lion Tcr Pte Ltd
Publication of SG11201708680PA publication Critical patent/SG11201708680PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11201708680PA 2016-03-31 2016-03-31 Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr) SG11201708680PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2016/050164 WO2017171631A1 (en) 2016-03-31 2016-03-31 Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr)

Publications (1)

Publication Number Publication Date
SG11201708680PA true SG11201708680PA (en) 2017-11-29

Family

ID=59965039

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201708680PA SG11201708680PA (en) 2016-03-31 2016-03-31 Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr)

Country Status (7)

Country Link
US (1) US11576932B2 (zh)
EP (1) EP3436572A4 (zh)
JP (1) JP2019509753A (zh)
KR (1) KR20190006952A (zh)
CN (2) CN118147079A (zh)
SG (1) SG11201708680PA (zh)
WO (1) WO2017171631A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11186624B2 (en) 2016-09-23 2021-11-30 Lion Tcr Pte. Ltd. HBV antigen specific binding molecules and fragments thereof
US20190119636A1 (en) 2017-10-23 2019-04-25 Poseida Therapeutics, Inc. Modified stem cell memory t cells, methods of making and methods of using same
CN110730821B (zh) 2016-12-16 2023-12-08 比莫根生物科技公司 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法
US11278570B2 (en) 2016-12-16 2022-03-22 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
US11760983B2 (en) 2018-06-21 2023-09-19 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
CN116144706A (zh) * 2018-08-13 2023-05-23 根路径基因组学公司 成对的二分免疫受体多核苷酸的高通量克隆及其应用
SG11202110956RA (en) 2019-04-05 2021-10-28 Rootpath Genomics Inc Compositions and methods for t-cell receptor gene assembly
WO2021148110A1 (en) 2020-01-21 2021-07-29 Lion Tcr Pte. Ltd. Hbv specific tcr library and its use as personalised medicine
EP4143219A2 (en) * 2020-04-27 2023-03-08 Vanderbilt University Lymphocytes lacking perforin function
US20230338532A1 (en) * 2020-09-11 2023-10-26 National University Of Singapore Immunosuppressant drug resistant armored tcr t cells for immune-therapy of organ transplant patients

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322211A1 (en) * 2001-07-12 2003-01-29 Canvac Methods and compisitions for activation human t cells in vitro
GB0509318D0 (en) * 2005-05-06 2005-06-15 Chiron Srl TCR-independent activation of T cells
CA2608193A1 (en) * 2005-05-11 2006-11-23 The Trustees Of The University Of Pennsylvania Methods for the rapid expansion of antigen specific t-cells
CN101501055B (zh) * 2005-06-23 2016-05-11 贝勒医学院 负性免疫调节因子的调节和免疫疗法应用
EP1795599A1 (en) * 2005-12-09 2007-06-13 Schuler, Gerold, Prof. Dr. Methods for generating antigen-specific effector T cells
CN101361969B (zh) * 2008-01-29 2011-05-11 广州市恺泰生物科技有限公司 一种治疗性乙肝疫苗及其制备方法和用途
ES2622505T3 (es) 2008-05-09 2017-07-06 Agency For Science, Technology And Research Receptor de linfocito T (RLT) exógeno reactivo contra epítopo de VHB y usos del mismo
ES2657846T3 (es) * 2010-04-29 2018-03-07 Epiontis Gmbh Detección de células inmunes, en particular linfocitos T mediante análisis de metilación de ADN de los genes CCR6
CN104080917B (zh) * 2011-09-29 2016-11-02 国家健康与医学研究院 用突变体BaEV糖蛋白假型化的慢病毒载体
KR102135239B1 (ko) 2012-08-20 2020-07-17 프레드 헛친슨 켄서 리서치 센터 세포 면역요법을 위한 방법 및 조성물
JP2015529685A (ja) * 2012-09-17 2015-10-08 ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ 筋萎縮性側索硬化症の処置のための組成物および方法
CN102964326B (zh) * 2012-11-06 2015-11-18 北京大学 具有mek抑制功能的化合物及其制备方法与应用
SI3080103T1 (sl) * 2013-12-11 2018-11-30 Biogen Ma Inc. Biarilne spojine, ki so uporabne za zdravljenje človeških bolezni na področju onkologije, nevrologije in imunologije
WO2015091823A1 (en) * 2013-12-19 2015-06-25 Friedrich-Alexander Universität Erlangen-Nürnberg Influenza-specific t-cell receptor and its uses in the detection, prevention and/or treatment of influenza
WO2016036746A1 (en) * 2014-09-02 2016-03-10 Bellicum Pharmaceuticals, Inc. Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
CN107106670A (zh) * 2014-10-31 2017-08-29 宾夕法尼亚大学董事会 用于修饰的t细胞的方法和组合物
JP7038353B2 (ja) * 2016-04-13 2022-03-18 ヴィヴィア バイオテック，エス．エル エクスビボのｂｉｔｅ活性化ｔ細胞
US11186624B2 (en) * 2016-09-23 2021-11-30 Lion Tcr Pte. Ltd. HBV antigen specific binding molecules and fragments thereof
SG10201705285SA (en) * 2017-06-27 2019-01-30 Agency Science Tech & Res Antisense oligonucleotides
US11903968B2 (en) * 2017-07-21 2024-02-20 Cellectis Engineered immune cells resistant to tumor microenvironment
AU2020226714A1 (en) * 2019-02-19 2021-08-26 European Molecular Biology Laboratory Cell penetrating transposase
CN111607565A (zh) * 2020-06-04 2020-09-01 河南大学 一种北平顶猴t细胞的体外扩增方法

Also Published As

Publication number Publication date
US20190192566A1 (en) 2019-06-27
EP3436572A1 (en) 2019-02-06
WO2017171631A1 (en) 2017-10-05
KR20190006952A (ko) 2019-01-21
JP2019509753A (ja) 2019-04-11
CN118147079A (zh) 2024-06-07
CN109477073B (zh) 2024-04-12
EP3436572A4 (en) 2019-11-20
US11576932B2 (en) 2023-02-14
CN109477073A (zh) 2019-03-15

Similar Documents

Publication Publication Date Title
SG11201708680PA (en) Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr)
IL287319A (en) Genetically modified cells containing a modified human t cell receptor alpha constant region gene
IL261910B (en) Electrolyte for a rechargeable electrochemical cell
SG11201609053YA (en) Multiplexed single cell gene expression analysis using template switch and tagmentation
GB2539612B (en) Positive electrode active material for lithium secondary cell
HUE045660T2 (hu) Cella ID menedzsment felfedezési referenciajelekhez kis cellák számára LTE rendszerben
EP3084870A4 (en) ELECTROCHEMICAL ENERGY CONVERTING DEVICES AND CELLS, AND POSITIVE ELECTRODE SIDE MATERIALS THEREOF
IL254565A0 (en) Production of t-cells specific for a virus antigen or other antigen from a population of naïve t-cells
EP3108224B8 (de) Referenzelektrodeneinsatz für eine elektrochemische testzelle
HK1258149A1 (zh) 用於電化學電池的安全陽極
EP3206246A4 (en) Electrolyte film for fuel cell
EP3688826A4 (en) BATTERY PACK INCLUDING A CELL RESTRICTION DEVICE
PL3529267T3 (pl) Receptor komórek t
ZA201802528B (en) Electrode-supported tubular solid-oxide electrochemical cell
GB201714180D0 (en) Transduced cell cryoformulation
EP3151320A4 (en) Redox catalyst, electrode material, electrode, membrane electrode assembly for fuel cells, and fuel cell
GB201710655D0 (en) Electrochemical cell
HUE050684T2 (hu) Elektrokémiai cella elektród szigetelõ kerettel
EP3368051A4 (en) GENERATION OF HPV ANTIGEN-SPECIFIC T CELLS FROM A NAIVEN T CELL POPULATION
PL3195397T3 (pl) Membrana elektrolitowa do zastosowania w ogniwie elektrochemicznym
ZA201804586B (en) Fuel cell electrolyte management device
PL3688825T3 (pl) Zestaw baterii zawierający ograniczenie dla ogniw
IL252248B (en) Electrode for electrochemical cells and their composition
GB2551997B (en) Battery cell arrangement
EP3548511A4 (en) METHODS AND MATERIALS FOR CLONING FUNCTIONAL T CELL RECEPTORS FROM T UNIQUE LYMPHOCYTES